- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News 443 results
In the News
März 10, 2025
Litigation and trial partner Eric White joins the firm’s Product Liability and Mass Torts practice group in Chicago
Press Release
März 10, 2025
Litigation and Trial Lawyer Eric White Joins King & Spalding in Chicago
Cases & Deals
Februar 24, 2025
King & Spalding Secures Another Victory for Boehringer Ingelheim in Zantac-Related Retrial
In the News
Recognition
Februar 13, 2025
Legal 500 Deutschland 2025 Ranks King & Spalding Among Germany’s Leading Law Firms
Recognition
Februar 13, 2025
Chambers Global 2025 Recognizes King & Spalding as a Leading International Law Firm
In the News
In the News
Januar 29, 2025
Cory Hohnbaum and Andy Bayman represent Boehringer Ingelheim in a Zantac-related trial before an Illinois state court
In the News
In the News
Januar 27, 2025
Kyle Gotchy discusses President Trump’s federal funding freeze and how it may impact the DEA’s recent proposed rule
In the News
Press Release
Januar 15, 2025
Lauren Roth, Former Leader of FDA’s Office of Policy, Joins King & Spalding’s FDA and Life Sciences Team